$country= Comparative statistics by cancer registry - SurvCan

Comparative statistics by cancer registry

Registry: Comparative statistics by cancer site

Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site

(Singapore, 1993-1997 cases followed-up until 2001)

Click on cancer site (ICD-10 code) for comparison
SiteICD-10TotalAbsolute survival %Relative survival %ASRS% at 5-years
1-year3-year5-year1-year3-year5-yearall ages0-74 years
C01-02Tongue12061.736.734.063.539.839.040.844.3
C03-06Oral cavity13564.443.034.566.947.640.645.449.2
C07-08Salivary gland8785.175.965.086.679.069.263.070.1
C09Tonsil3865.847.436.167.349.939.238.344.7
C11Nasopharynx140486.668.156.787.570.159.553.659.2
C12-13Hypopharynx9043.317.88.745.120.010.611.011.9
C15Oesophagus44625.18.35.326.49.26.29.312.1
C16Stomach210043.124.219.445.027.123.323.927.4
C17Small intestine8051.335.022.452.838.125.825.428.5
C18Colon250170.351.041.873.056.950.249.552.5
C19-20Rectum175373.552.542.776.158.050.449.052.1
C21Anus5360.437.731.863.944.341.939.540.4
C22Liver155018.36.84.419.07.55.16.06.5
C23-24Gall bladder28934.917.011.936.318.814.015.018.3
C25Pancreas51211.55.33.412.05.84.04.14.8
C30-31Nose/Sinuses7171.849.340.873.953.145.944.350.4
C32Larynx31177.854.347.381.061.057.161.065.7
C33-34Lung425328.99.06.030.210.17.27.79.3
C37-38Other thoracic organs6368.350.844.269.052.346.233.841.0
C40-41Bone6167.247.537.267.748.738.541.838.5
C43Melanoma skin6071.745.034.773.948.739.439.944.5
C44Other skin103793.182.775.297.795.695.895.695.2
C45Mesothelioma3423.511.88.424.012.28.88.311.4
C47+C49Connective tissue16672.354.251.273.656.955.148.257.1
C48Peritoneum4060.032.524.960.833.325.819.226.2
C50Breast320493.080.672.194.083.276.273.976.4
C51Vulva3580.057.154.382.561.762.067.066.4
C53Cervix98484.265.559.985.367.963.563.265.7
C54Corpus uteri48390.381.076.491.383.680.676.579.6
C56Ovary71881.867.561.282.769.363.756.262.4
C60Penis4182.970.755.585.778.566.270.374.8
C61Prostate75282.457.744.688.270.863.061.364.3
C62Testis7592.089.385.192.490.386.788.288.2
C64Kidney36966.449.945.368.253.450.747.255.0
C65Renal pelvis4447.734.131.549.337.036.132.443.9
C67Urinary bladder49676.658.951.880.267.064.062.771.9
C70-72Brain & nervous system29056.935.230.257.535.830.927.629.6
C73Thyroid55492.188.886.393.291.490.389.591.2
C74Adrenal gland2860.742.939.361.443.439.923.532.1
C81Hodgkin lymphoma7387.776.769.688.478.371.973.175.4
C82-85+C96Non-Hodgkin lymphoma79059.545.942.561.149.047.149.252.0
C90Multiple myeloma15954.728.317.256.630.819.422.326.0
C91Lymphoid leukaemia20568.350.244.868.851.145.935.942.9
C92-94Myeloid leukaemia39042.122.616.743.123.617.719.322.6
C95Leukaemia unspecified7222.212.58.322.913.49.010.712.9


Graphs:


Other tables available for this registry:
- Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Singapore, 1993-1997 cases followed-up until 2001)
- Table2b: Number and proportion of cases by vital status and median follow-up (in months) by site (Singapore, 1993-1997 cases followed-up until 2001)
- Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Singapore, 1993-1997 cases followed-up until 2001)
- Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Singapore, 1993-1997 cases followed-up until 2001)
- Table5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site (Singapore, 1993-1997)
- Table6: Comparison of 5-year absolute and relative survival of cases diagnosed between 1988-1992 and 1993-1997 (Singapore)
- Table7b: Number of cases by cancer site and calendar period (Singapore Cancer Registry, 1968-1997)
- Table8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period (Singapore, 1968-1997 cases followed-up until 1997)
- Table9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period (Singapore, 1968-1997 cases followed-up until 1997)




Registry chapter:


Consult the chapter in Cancer survival in developping countries (Volume II)